Odiparcil For The Prevention Of Venous Thromboembolism

Summary

Odiparcil is being studied to determine if it can prevent blood clots from forming after a total knee replacement and also to prove that odiparcil is safe.

Timeline

Start

2005-09

Primary completion

2006-09

Completion

2006-09

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Odiparcil MR 250 mg Tablet vs Warfarin INR 2.0 to 3.0; p = 0.012; Risk Ratio (RR) 1.45 (95% CI 1.1 to 1.9); Fisher Exact NCT00244725 ↗

Drugs

Indications